Johnson & Johnson
JNJ
$204.75
$2.141.05%
NYSE
| 09/28/2025 | 06/29/2025 | 03/30/2025 | 12/29/2024 | 09/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.08% | 4.68% | 4.30% | 4.30% | 4.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.08% | 4.68% | 4.30% | 4.30% | 4.77% |
| Cost of Revenue | 9.08% | 8.61% | 7.42% | 4.61% | 4.84% |
| Gross Profit | 3.33% | 2.97% | 2.95% | 4.16% | 4.74% |
| SG&A Expenses | 6.82% | 4.87% | 5.47% | 8.16% | 7.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.92% | 8.62% | 7.76% | 8.16% | 8.14% |
| Operating Income | 5.51% | -5.46% | -4.68% | -5.57% | -3.50% |
| Income Before Tax | 78.72% | 40.21% | 32.60% | 10.79% | 25.22% |
| Income Tax Expenses | 123.26% | 50.05% | 60.28% | 50.98% | 72.75% |
| Earnings from Continuing Operations | 70.10% | 38.33% | 27.75% | 5.55% | 18.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -100.37% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.06% | -40.39% | -43.32% | -59.99% | -57.59% |
| EBIT | 5.51% | -5.46% | -4.68% | -5.57% | -3.50% |
| EBITDA | 5.85% | -2.42% | -2.78% | -3.53% | -2.32% |
| EPS Basic | 77.23% | -37.64% | -40.12% | -57.54% | -56.82% |
| Normalized Basic EPS | 1.67% | -4.31% | 0.59% | 1.71% | 12.12% |
| EPS Diluted | 77.40% | -37.40% | -39.94% | -57.43% | -56.62% |
| Normalized Diluted EPS | 1.73% | -4.20% | 0.79% | 1.61% | 12.33% |
| Average Basic Shares Outstanding | -3.40% | -4.52% | -6.29% | -8.04% | -3.51% |
| Average Diluted Shares Outstanding | -3.46% | -4.63% | -6.47% | -7.97% | -3.81% |
| Dividend Per Share | 4.53% | 4.37% | 4.20% | 4.47% | 4.74% |
| Payout Ratio | -0.39% | 1.33% | 1.39% | 2.32% | 2.07% |